Tokyo Tape
Sign in
← StemCell Institute

Annual report

7096.TEDINET S100TW62
Period2023-04-01 → 2024-03-31
Filed2024-06-27
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 81
MetricValuePeriodScopeSource row
Revenue¥2.5bn2023-04-01 → 2024-03-31StandaloneNet sales
Revenue¥2.1bn2022-04-01 → 2023-03-31StandaloneNet sales
Revenue¥1.8bn2021-04-01 → 2022-03-31dStandaloneNet sales (5-year summary)
Revenue¥1.4bn2020-04-01 → 2021-03-31dStandaloneNet sales (5-year summary)
Revenue¥1.7bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Operating income¥414m2023-04-01 → 2024-03-31StandaloneOperating income
Operating income¥298m2022-04-01 → 2023-03-31StandaloneOperating income
Ordinary income¥417m2023-04-01 → 2024-03-31StandaloneOrdinary income
Ordinary income¥300m2022-04-01 → 2023-03-31StandaloneOrdinary income
Ordinary income¥213m2021-04-01 → 2022-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥92m2020-04-01 → 2021-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥383m2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥441m2023-04-01 → 2024-03-31StandaloneIncome before income taxes
Profit before tax¥279m2022-04-01 → 2023-03-31StandaloneIncome before income taxes
Net income¥311m2023-04-01 → 2024-03-31StandaloneProfit loss
Net income¥198m2022-04-01 → 2023-03-31StandaloneProfit loss
Net income¥134m2021-04-01 → 2022-03-31dStandaloneNet income loss (5-year summary)
Net income¥62m2020-04-01 → 2021-03-31dStandaloneNet income loss (5-year summary)
Net income¥277m2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Total assets¥6.5bnat 2024-03-31StandaloneAssets
Total assets¥5.8bnat 2023-03-31StandaloneAssets
Total assets¥5.2bnat 2022-03-31dStandaloneTotal assets (5-year summary)
Total assets¥4.0bnat 2021-03-31dStandaloneTotal assets (5-year summary)
Total assets¥3.6bnat 2020-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥3.9bnat 2024-03-31StandaloneLiabilities
Total liabilities¥3.5bnat 2023-03-31StandaloneLiabilities
Net assets / equity¥2.7bnat 2024-03-31StandaloneNet assets
Net assets / equity¥2.3bnat 2023-03-31StandaloneNet assets
Net assets / equity¥2.1bnat 2022-03-31dStandaloneNet assets
Net assets / equity¥1.3bnat 2021-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥1.3bnat 2020-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥2.8bnat 2024-03-31StandaloneCash and deposits
Cash and deposits¥3.3bnat 2023-03-31StandaloneCash and deposits
Cash & equivalents¥2.8bnat 2024-03-31StandaloneCash and cash equivalents
Cash & equivalents¥3.3bnat 2023-03-31StandaloneCash and cash equivalents
Cash & equivalents¥3.5bnat 2022-03-31dStandaloneCash and cash equivalents
Cash & equivalents¥2.0bnat 2021-03-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥2.3bnat 2020-03-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥335m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow¥100m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in operating activities
Operating cash flow¥469m2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥239m2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥668m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥812m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥285m2022-04-01 → 2023-03-31StandaloneNet cash provided by used in investment activities
Investing cash flow¥404m2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥520m2020-04-01 → 2021-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥108m2019-04-01 → 2020-03-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥1m2023-04-01 → 2024-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥869,0002022-04-01 → 2023-03-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥644m2021-04-01 → 2022-03-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥30.352023-04-01 → 2024-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥19.332022-04-01 → 2023-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥13.22021-04-01 → 2022-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥6.412020-04-01 → 2021-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥28.512019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥262.78at 2024-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥224.33at 2023-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥205.33at 2022-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥135.83at 2021-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥129.42at 2020-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio41.1%at 2024-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio39.6%at 2023-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio40.3%at 2022-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio33.4%at 2021-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio35.3%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE12.5%2023-04-01 → 2024-03-31StandaloneRate of return on equity (5-year summary)
ROE9.0%2022-04-01 → 2023-03-31StandaloneRate of return on equity (5-year summary)
ROE7.8%2021-04-01 → 2022-03-31dStandaloneRate of return on equity (5-year summary)
ROE4.8%2020-04-01 → 2021-03-31dStandaloneRate of return on equity (5-year summary)
ROE24.8%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued10,246,600at 2024-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued10,246,600at 2023-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued5,123,300at 2022-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued4,867,100at 2021-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued4,867,100at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees98at 2024-03-31StandaloneNumber of employees
Employees92at 2023-03-31StandaloneNumber of employees
Employees82at 2022-03-31dStandaloneNumber of employees
Employees79at 2021-03-31dStandaloneNumber of employees
Employees84at 2020-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 803
ItemContextValueUnit
Other net inv cfPrior1YearDuration_NonConsolidatedMember-35246000JPY
Other net inv cfCurrentYearDuration_NonConsolidatedMember24238000JPY
Net cash provided by used in investment activitiesPrior1YearDuration_NonConsolidatedMember-285100000JPY
Net cash provided by used in investment activitiesCurrentYearDuration_NonConsolidatedMember-811773000JPY
Repayments of lease obligations fin cfPrior1YearDuration_NonConsolidatedMember-777000JPY
Repayments of lease obligations fin cfCurrentYearDuration_NonConsolidatedMember-1333000JPY
Purchase of treasury stock fin cfPrior1YearDuration_NonConsolidatedMember-91000JPY
Purchase of treasury stock fin cfCurrentYearDuration_NonConsolidatedMember－JPY
Net cash provided by used in financing activitiesPrior1YearDuration_NonConsolidatedMember-869000JPY
Net cash provided by used in financing activitiesCurrentYearDuration_NonConsolidatedMember-1333000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YearDuration_NonConsolidatedMember－JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYearDuration_NonConsolidatedMember－JPY
Net increase decrease in cash and cash equivalentsPrior1YearDuration_NonConsolidatedMember-186297000JPY
Net increase decrease in cash and cash equivalentsCurrentYearDuration_NonConsolidatedMember-478480000JPY
Cash and cash equivalentsPrior2YearInstant_NonConsolidatedMember3510318000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember3324021000JPY
Cash and cash equivalentsPrior1YearInstant_NonConsolidatedMember3324021000JPY
Cash and cash equivalentsCurrentYearInstant_NonConsolidatedMember2845540000JPY
Salaries and allowances sgaPrior1YearDuration_NonConsolidatedMember228949000JPY
Salaries and allowances sgaCurrentYearDuration_NonConsolidatedMember258361000JPY
Advertising expenses sgaPrior1YearDuration_NonConsolidatedMember194075000JPY
Advertising expenses sgaCurrentYearDuration_NonConsolidatedMember196784000JPY
Commission fee sgaPrior1YearDuration_NonConsolidatedMember113774000JPY
Commission fee sgaCurrentYearDuration_NonConsolidatedMember164018000JPY
Depreciation sgaPrior1YearDuration_NonConsolidatedMember12567000JPY
Depreciation sgaCurrentYearDuration_NonConsolidatedMember19175000JPY
Provision for bonuses sgaPrior1YearDuration_NonConsolidatedMember27145000JPY
Provision for bonuses sgaCurrentYearDuration_NonConsolidatedMember27381000JPY
Provision for directors retirement benefits sgaPrior1YearDuration_NonConsolidatedMember12293000JPY
Provision for directors retirement benefits sgaCurrentYearDuration_NonConsolidatedMember11062000JPY
Provision of allowance for doubtful accounts sgaPrior1YearDuration_NonConsolidatedMember2382000JPY
Provision of allowance for doubtful accounts sgaCurrentYearDuration_NonConsolidatedMember1988000JPY
Research and development expenses sgaPrior1YearDuration_NonConsolidatedMember9473000JPY
Research and development expenses sgaCurrentYearDuration_NonConsolidatedMember11424000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)有価証券報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2024-06-27
Fiscal year cover pageFilingDateInstant
Original text (Japanese)第25期(自　2023年４月１日　至　2024年３月31日)
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社ステムセル研究所
Company name in english cover pageFilingDateInstantStemCell Institute Inc.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　清水　崇文
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都港区虎ノ門一丁目21番19号
Telephone number address of registered headquarter cover pageFilingDateInstant０３－６８１１－３２３０
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)執行役員管理本部長　　谷　勝弘
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都港区虎ノ門一丁目21番19号
Telephone number nearest place of contact cover pageFilingDateInstant０３－６８１１－３２３５
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)執行役員管理本部長　　谷　勝弘
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE35563

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2023-03-31pass rounding
balance sheet identitynon_consolidated 2024-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2023-03-31pass
statement vs summary · net assetsnon_consolidated 2024-03-31pass
statement vs summary · operating cash flownon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · operating cash flownon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · revenuenon_consolidated 2022-04-01/2023-03-31pass
statement vs summary · revenuenon_consolidated 2023-04-01/2024-03-31pass
statement vs summary · total assetsnon_consolidated 2023-03-31pass
statement vs summary · total assetsnon_consolidated 2024-03-31pass